Estelle Vester-Blokland, MD - Bristol Myers Squibb

Estelle Vester-Blokland

Senior Vice President, Global Medical Affairs

As senior vice president, Global Medical Affairs, Estelle Vester-Blokland leads the company’s efforts to implement the safe and appropriate use of its medicines into clinical practice and gather insight into medical practices and patient needs from stakeholders. Global Medical Affairs collaborates with clinical drug development and the commercial organization to gain a deep understanding of medical needs and help deliver innovative medicines to patients.

As a member of the Bristol Myers Squibb leadership team, Estelle reports to our chief commercialization officer, Chris Boerner.

“Global Medical Affairs plays a critical role in engaging the medical community and implementing our science into clinical practice,” Estelle says. "With our innovative portfolio of therapies, and one of the most diverse and promising pipelines in the industry, we must clearly demonstrate the value of our medicines for patients and healthcare systems to help inform clinical decisions in a dynamic healthcare environment.”

Estelle’s valuable industry leadership and insight comes from more than 25 years of experience in medical affairs and product strategy across the U.S. and Europe. Before rejoining Bristol Myers Squibb in 2021, she spent two years at Novartis as worldwide head of Medical Affairs for Neuroscience; she has also served as a lifecycle leader in Global Product Strategy and head of Personalized Medicine in Global Medical Affairs at Roche. A physician by training, her background spans several therapeutic areas, including neuroscience and oncology; she is passionate about individualized, patient-centered care.

Estelle earned her doctor of medicine degree at Utrecht University in the Netherlands and worked for two years as an internal medicine physician before joining the industry.

Updated: December 2021